A new artificial intelligence test is set to improve prostate cancer treatment selection by accurately predicting which men will benefit most from abiraterone, a drug that can halve the risk …
© Copyright by Brunei TV News (A Digital Media Brand owned by AMAZON MEDIA LLC).